Network origin in Martin Shkreli first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 14 | |
| Public Company | Pharmaceuticals: Major | 12 | |
Desert Gateway, Inc.
 Desert Gateway, Inc. Financial ConglomeratesFinance Desert Gateway, Inc. operates as a capital pool company. It is presently a development stage company seeking a potential acquisition of or merger with a yet to be identified business opportunity. The company was founded on February 8, 2008 and is headquartered in Bartlesville, OK.
3
| Extinct | Financial Conglomerates | 3 |
Intrepid Capital Management, Inc. (Florida)
 Intrepid Capital Management, Inc. (Florida) Investment ManagersFinance Intrepid Capital Management, Inc. (Intrepid Capital) is a registered investment advisor headquartered in Jacksonville Beach, Florida. The firm was founded by Forrest Travis and Mark Travis in 1994. They are a wholly-owned subsidiary of Intrepid Capital Corp. (NASDAQ: ICAP). Intrepid Capital provides advisory services and non-advisory services to corporate, institutional, and high net worth individuals. They also provide advisory services to mutual funds (registered investment companies) and pooled investment vehicles that are not registered as investment companies.
3
| Subsidiary | Investment Managers | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martin Shkreli via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing Sales & Marketing Director/Board Member | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| NEUROLOGIX, INC. | Internet Software/Services | Director of Finance/CFO Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
UBS Securities LLC
 UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Analyst-Equity | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Banks/Brokers | Analyst-Equity | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Compliance Officer | |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Investment Banks/Brokers | Analyst-Equity | |
| Kalobios Pharmaceuticals, Inc. | Chairman Director/Board Member Director/Board Member | ||
| JASPER THERAPEUTICS, INC. | Financial Conglomerates | Director of Finance/CFO Chief Executive Officer | |
| St. John's University | College/University | Undergraduate Degree Masters Business Admin | |
| Yale School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Comptroller/Controller/Auditor Director/Board Member | |
| PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Eterna Therapeutics LLC
 Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Eterna Therapeutics, Inc., Eterna Therapeutics LLC is a clinical-stage biopharmaceutical company based in New York, NY. The company is focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer. Eterna Therapeutics is committed to developing irx-2, a novel cytokine-based therapy, to treat patients with cancer. The active constituents of irx-2, namely interleukin-2 (il-2) and other key cytokines, are postulated to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. Eterna Therapeutics is a late clinical-stage biopharmaceutical company focused on il-2 cytokine-based therapies in treating patients with cancer. Eterna Therapeutics was acquired by NTN Buzztime, Inc. on March 25, 2021 for $213.30 million. | Pharmaceuticals: Major | Chief Executive Officer | |
| ETERNA THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Royal Hibernian Academy | College/University | Graduate Degree | |
| ENTERO THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| RELMADA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Rutgers Business School | College/University | Masters Business Admin | |
| Caldwell College | College/University | Undergraduate Degree | |
| Yale Graduate School of Arts & Sciences | College/University | Doctorate Degree | |
| University of California | College/University | Undergraduate Degree | |
Sova Pharmaceuticals, Inc.
 Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
International Association for the Study of Pain
 International Association for the Study of Pain Miscellaneous Commercial ServicesCommercial Services International Association for the Study of Pain operates as a professional forum for science, practice, and education in the field of pain. It brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain. The company was founded in 1973 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Society For Neuroscience
 Society For Neuroscience Miscellaneous Commercial ServicesCommercial Services The Society for Neuroscience is an organization with over 36,000 members in more than 95 countries. The non-profit company is based in Washington. The organization also engages in science advocacy and public policy, including an annual Capitol Hill Day, and has various public outreach efforts, such as the interactive collection of public-facing resources on BrainFacts.org. It was founded in 1969 and offers year-round programming, including the publication of two scientific journals, professional development resources, and career training through Neuronline. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American College of Neuropsychopharmacology
 American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistics
International
| United States | 43 |
| Denmark | 2 |
| Ireland | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 10 |
| Finance | 7 |
| Commercial Services | 7 |
| Technology Services | 2 |
Operational
| Director/Board Member | 98 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 38 |
| Chief Executive Officer | 26 |
| Director of Finance/CFO | 21 |
Most connected contacts
| Insiders | |
|---|---|
| Srinivas Rao | 22 |
| Stephen Aselage | 20 |
| Gary Lyons | 20 |
| Cornelius E. Golding | 18 |
| Ronald Martell | 16 |
| Maged Shenouda | 16 |
| Herbert Cross | 14 |
| Laurie Alsup | 14 |
| Jeff Paley | 14 |
| Robert Baffi | 12 |
| Denise M. Gilbert | 11 |
| Alvin Shih | 11 |
| Ronald Guido | 9 |
| David Moradi | 8 |
| Raymond M. Withy | 8 |
- Stock Market
- Insiders
- Martin Shkreli
- Company connections
